MKS Instruments Q1 revenue rose 15% as a new Malaysia site and $180B WFE outlook support 2027 growth. Learn why MKSI stock is ...

SAMR antitrust probe: fines risk, valuation at 11–12x EV/EBITDA, buybacks, and travel growth outlook—get the key stock ...

Q1 2026 earnings call recap: backlog up 50% to $9M, Q2 revenue accelerating, and new EV charging/drone catalysts.

Western Midstream Partners (WES) yields 8.35% with 5–8% distribution growth; Q1 beat and Brazos deal boost returns. See here ...

Near-term highs in retail money funds are always associated with the level of market pessimism and closely correlate with ...

Looking at royalties, Mr. Lube + Tires distributed approximately $34.1 million to Diversified in FY 2025. That's basically ...

Lowe’s (LOW) may announce its 64th dividend hike in May; see yield and growth outlook, pro-customer strategy, plus other ...

Although the index is lower to round out the week, the S&P 500 repeatedly reached more record highs recently. Of the 24 ...

Discusses Extended Follow-Up Data From Phase 3 Trial of aglatimagene besadenovec in Localized Prostate Cancer May 15, ...

Chord Energy looks undervalued after a 40% rise, with 20%+ FCF yields and 4-mile wells driving growth. See here for more on ...

Q1 2026 earnings call: neffy revenue growth, CVS Caremark prior-auth update, $199 cash option, guidance & risks.

Good morning, and welcome to ARS Pharmaceuticals First Quarter 2026 Earnings Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded. I will now turn the ...